A handful of B.C. communities are helping to set the stage for the future of cancer treatments.

BC Cancer has launched a clinical trial called SIMPLIFY, led by BC Cancer oncologist Dr. Rob Olsen, Executive Medical Director in Prince George, to test whether a single, targeted dose of Stereotactic Ablative Radiotherapy (SABR) can effectively treat oligometastatic cancer.

“SABR represents the future of cancer care,” said Dr. Olson. “We’re proud that BC Cancer is at the forefront of this research, providing our patients with the most advanced care available worldwide. Our goal is not only to improve outcomes but to enhance the patient experience by reducing side effects and easing the burden of accessing care, especially for patients and families in rural communities.

The trial is now open

See Full Page